Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Schumann

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Leukemia|January 5, 2019
Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapiesNeşe Çakmak-Görür, Josefine Radke, Simone Rhein, et al.
Acta Neuropathologica Communications|June 7, 2019
Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patientsJosefine Radke, Arend Koch, Fabienne Pritsch, et al.
Acta Neuropathologica|February 22, 2024
MET receptor serves as a promising target in melanoma brain metastasesTorben Redmer, Elisa Schumann, Kristin Peters, et al.
Acta Neuropathologica|March 27, 2024
Correction to: MET receptor serves as a promising target in melanoma brain metastasesTorben Redmer, Elisa Schumann, Kristin Peters, et al.
JAMA Network Open|April 29, 2022
Effectiveness of Immune Checkpoint Inhibition vs Chemotherapy in Combination With Radiation Therapy Among Patients With Non-Small Cell Lung Cancer and Brain Metastasis Undergoing Neurosurgical ResectionDavid Wasilewski, Josefine Radke, Ran Xu, et al.
BMC Cancer|September 11, 2019
CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testingLena Andersch, Josefine Radke, Anika Klaus, et al.
Nature Communications|November 26, 2022
Decoding molecular programs in melanoma brain metastasesJosefine Radke, Elisa Schumann, Julia Onken, et al.
Nature Communications|May 10, 2022
The genomic and transcriptional landscape of primary central nervous system lymphomaJosefine Radke, Naveed Ishaque, Randi Koll, et al.
Nature Neuroscience|December 1, 2020
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19Jenny Meinhardt, Josefine Radke, Carsten Dittmayer, et al.
Nature Neuroscience|February 17, 2024
Proteomic and transcriptomic profiling of brainstem, cerebellum and olfactory tissues in early- and late-phase COVID-19Josefine Radke, Jenny Meinhardt, Tom Aschman, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Leukemia|January 5, 2019
Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapiesNeşe Çakmak-Görür, Josefine Radke, Simone Rhein, et al.
Acta Neuropathologica Communications|June 7, 2019
Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patientsJosefine Radke, Arend Koch, Fabienne Pritsch, et al.
Acta Neuropathologica|February 22, 2024
MET receptor serves as a promising target in melanoma brain metastasesTorben Redmer, Elisa Schumann, Kristin Peters, et al.
Acta Neuropathologica|March 27, 2024
Correction to: MET receptor serves as a promising target in melanoma brain metastasesTorben Redmer, Elisa Schumann, Kristin Peters, et al.
JAMA Network Open|April 29, 2022
Effectiveness of Immune Checkpoint Inhibition vs Chemotherapy in Combination With Radiation Therapy Among Patients With Non-Small Cell Lung Cancer and Brain Metastasis Undergoing Neurosurgical ResectionDavid Wasilewski, Josefine Radke, Ran Xu, et al.
BMC Cancer|September 11, 2019
CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testingLena Andersch, Josefine Radke, Anika Klaus, et al.
Nature Communications|November 26, 2022
Decoding molecular programs in melanoma brain metastasesJosefine Radke, Elisa Schumann, Julia Onken, et al.
Nature Communications|May 10, 2022
The genomic and transcriptional landscape of primary central nervous system lymphomaJosefine Radke, Naveed Ishaque, Randi Koll, et al.
Nature Neuroscience|December 1, 2020
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19Jenny Meinhardt, Josefine Radke, Carsten Dittmayer, et al.
Nature Neuroscience|February 17, 2024
Proteomic and transcriptomic profiling of brainstem, cerebellum and olfactory tissues in early- and late-phase COVID-19Josefine Radke, Jenny Meinhardt, Tom Aschman, et al.
Pageof 1